NASDAQ:ENGN | Balance Sheet | enGene Therapeutics Inc.

Complete source-backed balance-sheet history.

Available history
2021-10-31 to 2026-04-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-04-30$29.83M$228.64M$270M$2.34M$1.38M$307.52M$1.79M$21.49M$52.36M$255.17M
2026-01-31$36.61M$239.34M$289.22M$2.44M$1.39M$337.11M$2.44M$24.61M$55.57M$281.55M
2025-10-31$50.15M$143.58M$201.39M$2.48M$1.36M$221.47M$6.69M$31.98M$53.76M$167.71M
2025-07-31$32.62M$169.29M$211.31M$1.88M$1.38M$245.55M$2.38M$20.44M$44.88M$200.67M
2025-04-30$57.55M$159.85M$227.97M$1.55M$1.38M$266.65M$1.57M$18M$39.36M$227.29M
2025-01-31$62.35M$151.47M$222.32M$1.37M$1.58M$285.93M$2.61M$12.96M$35.98M$249.95M
2024-10-31$173M$65.33M$247.36M$1.17M$1.37M$311.17M$1.41M$14.66M$38.56M$272.61M
2024-07-31$257.68M$262.69M$1.01M$1.38M$266.88M$2.86M$13.46M$36.55M$230.33M
2024-04-30$264.81M$269.61M$1.11M$975,000.00$273.53M$211,000.00$6.3M$30.56M$242.97M
2024-01-31$85.65M$89.58M$993,000.00$974,000.00$93.42M$1.28M$6.91M$31.04M$62.39M
2023-10-31$81.52M$85.44M$589,000.00$930,000.00$86.96M$1.16M$5.26M$14.47M$72.49M
2023-07-31-$93.92M
2023-04-30-$89.24M
2023-01-31-$84.01M
2022-10-31$20.43M$22.58M$387,000.00$939,000.00$23.91M$723,000.00$5.1M$47.41M-$76.61M
2021-10-31$11.02M-$53.44M